| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $35.4M | +67.2% |
| SG&A Expense | $14.7M | +47.4% |
| Operating Income | -$50.0M | -60.9% |
| Pre-tax Income | -$46.4M | -54.3% |
| Income Tax | $1K | +0.0% |
| Net Income | -$46.4M | -54.3% |
| EPS (Basic) | -$0.82 | -151.9% |
| EPS (Diluted) | -$0.82 | -151.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $38.5M | +62.1% |
| Short-term Investments | $37.2M | — |
| Current Assets | $82.3M | +192.2% |
| Total Assets | $84.2M | +173.8% |
| Current Liabilities | $7.5M | -11.9% |
| Total Liabilities | $7.8M | -18.7% |
| Stockholders' Equity | $76.4M | +260.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$41.7M | -55.7% |
| Capital Expenditures | $340K | -44.5% |
| Investing Cash Flow | -$36.0M | -348.3% |
| Financing Cash Flow | $92.4M | +682.1% |
| Free Cash Flow | -$42.0M | -53.4% |